The October issue of #AABBNews delves into ethical issues in transfusion medicine and biotherapies, like blood doping to qualify patients in clinical trials. https://t.co/eEtJdb27C3
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation https://t.co/c8dxWxQbxk #COVID19
🗣️ Attention #blooducation community! AABB's National Blood Foundation is accepting grant applications from early-stage researchers. Submit your application through Dec. 1. https://t.co/ADCGutVtLD #AABBnbf
COVID-19 can affect anyone, regardless of their race or ethnicity. However, data show that #COVID19 impacts African Americans much more. Learn how #COVID19 affects African Americans and what researchers are doing to help #ConquerCOVID19: https://t.co/9cevztSbI1 #NIH
#DYK that when you get vaccinated, you’re protecting yourself, your family, & your community? That’s why NIH-funded scientists are working hard to find a #COVID19 vaccine to help #stopthespread. Learn more: https://t.co/9cevzu9Mzz #NIH
@DukeMargolis core faculty @DrCharleneWong writes in @JAMAHealthForum that the return to school is a massive natural experiment that can and should generate highly valuable evidence
https://t.co/GqayfzZclF
Why has the United States handled this pandemic so badly? The Editors note that although we came into this crisis with enormous advantages, our current political leaders have demonstrated that they are dangerously incompetent.
We, along with @ASHCollab, are excited to get to work with the #SCD community. Similar platforms have improved health care for other diseases & we are optimistic for this model in improving the lives of people living w/#sicklecell disease.
What an amazing ride! THANK YOU for attending #AABB20. We truly cannot wait to see you in Anaheim for #AABB21. Keep shining and tweeting AABB community!
In patients with severe #COVID19 the IL-6 receptor antagonist Tocilizumab appeared to shut down inflammation & procoagulation in a small pilotstudy, D-dimer & CRP declined rapidly; lymphocytes increased. Can this lead to better outcomes? #RPTH: https://t.co/QIrZahkqq7 @Littenberg
Congratulations to Dr. Harvey J. Alter, a former longtime member of AABB’s TTD Committee, on being awarded the 2020 Nobel Prize in Physiology or Medicine, along with Michael Houghton and Charles M. Rice, for the discovery of hepatitis C virus! #AABB20 https://t.co/B2LY5t7kvl